Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control

OnkoNetwork is a patient navigation program established in the Moritz Kaposi General Hospital to improve the timeliness and completeness of cancer investigations and treatment. The H2020 SELFIE consortium selected OnkoNetwork as a promising integrated care initiative in Hungary and conducted a multi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2022-10, Vol.17 (10), p.e0276719-e0276719
Hauptverfasser: Pitter, János G, Moizs, Mariann, Ezer, Éva Somogyiné, Lukács, Gábor, Szigeti, Annamária, Repa, Imre, Csanádi, Marcell, Rutten-van Mölken, Maureen P. M. H, Islam, Kamrul, Kaló, Zoltán, Vokó, Zoltán
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0276719
container_issue 10
container_start_page e0276719
container_title PloS one
container_volume 17
creator Pitter, János G
Moizs, Mariann
Ezer, Éva Somogyiné
Lukács, Gábor
Szigeti, Annamária
Repa, Imre
Csanádi, Marcell
Rutten-van Mölken, Maureen P. M. H
Islam, Kamrul
Kaló, Zoltán
Vokó, Zoltán
description OnkoNetwork is a patient navigation program established in the Moritz Kaposi General Hospital to improve the timeliness and completeness of cancer investigations and treatment. The H2020 SELFIE consortium selected OnkoNetwork as a promising integrated care initiative in Hungary and conducted a multicriteria decision analysis based on health, patient experience, and cost outcomes. In this paper, a more detailed analysis of clinical impacts is provided in the largest subgroup, non-small cell lung cancer (NSCLC) patients. A retrospective cohort study was conducted, enrolling new cancer suspect patients with subsequently confirmed NSCLC in two annual periods, before and after OnkoNetwork implementation (control and intervention cohorts, respectively). To control for selection bias and confounding, baseline balance was improved via propensity score weighting. Overall survival was analyzed in univariate and multivariate weighted Cox regression models and the effect was further characterized in a counterfactual analysis. Our analysis included 123 intervention and 173 control NSCLC patients from early to advanced stage, with significant between-cohort baseline differences. The propensity score-based weighting resulted in good baseline balance. A large survival benefit was observed in the intervention cohort, and intervention was an independent predictor of longer survival in a multivariate analysis when all baseline characteristics were included (HR = 0.63, p = 0.039). When post-baseline variables were included in the model, belonging to the intervention cohort was not an independent predictor of survival, but the survival benefit was explained by slightly better stage distribution and ECOG status at treatment initiation, together with trends for broader use of PET-CT and higher resectability rate. In conclusion, patient navigation is a valuable tool to improve cancer outcomes by facilitating more timely and complete cancer diagnostics. Contradictory evidence in the literature may be explained by common sources of bias, including the wait-time paradox and adjustment to intermediate outcomes.
doi_str_mv 10.1371/journal.pone.0276719
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2728446507</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A724025477</galeid><doaj_id>oai_doaj_org_article_58ed73a0d71a49efabbb769b2cdfd723</doaj_id><sourcerecordid>A724025477</sourcerecordid><originalsourceid>FETCH-LOGICAL-c669t-dfde45ef4dae97a6a53495fd22041931cd8be41ba3b1e05f6f93862612e3ab33</originalsourceid><addsrcrecordid>eNqNk12L1DAUhosouK7-A8GAIHoxY5t-ZOrFwrD4MbCwoIu34TQ5bTO0SU3SrvOb_JOmO1V2ZC-k0KbJc95z8p4kil4m8TpJWfJ-b0aroVsPRuM6pqxgSfkoOkvKlK4KGqeP742fRs-c28dxnm6K4iz6tesHayaUxI12UhN0xNREG71yPXQdERhe3agbIkALtGQAr1B7R6D24Vdpb40chQrEskQ0TKoJY6M_kC2xGAg3oPBqQiJMa6wnzo_yQG6Vb0lIP6B2yh-IE8YiuUXVtD5U1CrnjVUiBM1ZuufRkxo6hy-W73l08-njzeWX1dX1593l9moliqL0K1lLzHKsMwlYMiggT7MyryWlcRZsSITcVJglFaRVgnFeF3UZvKBFQjGFKk3Po1dH2aEzji_eOk4Z3WRZkccsELsjIQ3s-WBVD_bADSh-N2Fsw8F6JTrk-QYlSyGWLIGsxBqqqmJFWVERymR0znaxZBurHqUIBlroTkRPV7RqeWMmXuZlniezwNtFwJofIzrPe-XmtoFGMy51Fxljc92v_0Ef3t1CNRA2oHRtQl4xi_Ito1lM8-xOa_0AFR6JvQoNw1qF-ZOAdycBc1Pxp29gdI7vvn39f_b6-yn75h7bInS-daYb5_PnTsHsCIpwHp3F-q_JSczne_THDT7fI77co_Q3vQwWbg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2728446507</pqid></control><display><type>article</type><title>Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Pitter, János G ; Moizs, Mariann ; Ezer, Éva Somogyiné ; Lukács, Gábor ; Szigeti, Annamária ; Repa, Imre ; Csanádi, Marcell ; Rutten-van Mölken, Maureen P. M. H ; Islam, Kamrul ; Kaló, Zoltán ; Vokó, Zoltán</creator><creatorcontrib>Pitter, János G ; Moizs, Mariann ; Ezer, Éva Somogyiné ; Lukács, Gábor ; Szigeti, Annamária ; Repa, Imre ; Csanádi, Marcell ; Rutten-van Mölken, Maureen P. M. H ; Islam, Kamrul ; Kaló, Zoltán ; Vokó, Zoltán</creatorcontrib><description>OnkoNetwork is a patient navigation program established in the Moritz Kaposi General Hospital to improve the timeliness and completeness of cancer investigations and treatment. The H2020 SELFIE consortium selected OnkoNetwork as a promising integrated care initiative in Hungary and conducted a multicriteria decision analysis based on health, patient experience, and cost outcomes. In this paper, a more detailed analysis of clinical impacts is provided in the largest subgroup, non-small cell lung cancer (NSCLC) patients. A retrospective cohort study was conducted, enrolling new cancer suspect patients with subsequently confirmed NSCLC in two annual periods, before and after OnkoNetwork implementation (control and intervention cohorts, respectively). To control for selection bias and confounding, baseline balance was improved via propensity score weighting. Overall survival was analyzed in univariate and multivariate weighted Cox regression models and the effect was further characterized in a counterfactual analysis. Our analysis included 123 intervention and 173 control NSCLC patients from early to advanced stage, with significant between-cohort baseline differences. The propensity score-based weighting resulted in good baseline balance. A large survival benefit was observed in the intervention cohort, and intervention was an independent predictor of longer survival in a multivariate analysis when all baseline characteristics were included (HR = 0.63, p = 0.039). When post-baseline variables were included in the model, belonging to the intervention cohort was not an independent predictor of survival, but the survival benefit was explained by slightly better stage distribution and ECOG status at treatment initiation, together with trends for broader use of PET-CT and higher resectability rate. In conclusion, patient navigation is a valuable tool to improve cancer outcomes by facilitating more timely and complete cancer diagnostics. Contradictory evidence in the literature may be explained by common sources of bias, including the wait-time paradox and adjustment to intermediate outcomes.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0276719</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Analysis ; Bias ; Cancer therapies ; Care and treatment ; Cell survival ; Cohort analysis ; Cost analysis ; Criminal investigations ; Decision analysis ; Diagnosis ; Evidence-based medicine ; Health insurance ; Hospitals ; Integrated delivery networks ; Integrated delivery systems ; Intervention ; Lung cancer ; Lung cancer, Non-small cell ; Lung diseases ; Medical diagnosis ; Medical prognosis ; Medicine and Health Sciences ; Methods ; Mortality ; Multiple criterion ; Multivariate analysis ; Non-small cell lung carcinoma ; Observational studies ; Patients ; Propensity scores ; Regression analysis ; Regression models ; Small cell lung carcinoma ; Subgroups ; Survival ; Weighting</subject><ispartof>PloS one, 2022-10, Vol.17 (10), p.e0276719-e0276719</ispartof><rights>COPYRIGHT 2022 Public Library of Science</rights><rights>2022 Pitter et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Pitter et al 2022 Pitter et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c669t-dfde45ef4dae97a6a53495fd22041931cd8be41ba3b1e05f6f93862612e3ab33</citedby><cites>FETCH-LOGICAL-c669t-dfde45ef4dae97a6a53495fd22041931cd8be41ba3b1e05f6f93862612e3ab33</cites><orcidid>0000-0002-6784-9215 ; 0000-0002-1004-1848 ; 0000-0001-8706-3159</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595513/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595513/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids></links><search><creatorcontrib>Pitter, János G</creatorcontrib><creatorcontrib>Moizs, Mariann</creatorcontrib><creatorcontrib>Ezer, Éva Somogyiné</creatorcontrib><creatorcontrib>Lukács, Gábor</creatorcontrib><creatorcontrib>Szigeti, Annamária</creatorcontrib><creatorcontrib>Repa, Imre</creatorcontrib><creatorcontrib>Csanádi, Marcell</creatorcontrib><creatorcontrib>Rutten-van Mölken, Maureen P. M. H</creatorcontrib><creatorcontrib>Islam, Kamrul</creatorcontrib><creatorcontrib>Kaló, Zoltán</creatorcontrib><creatorcontrib>Vokó, Zoltán</creatorcontrib><title>Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control</title><title>PloS one</title><description>OnkoNetwork is a patient navigation program established in the Moritz Kaposi General Hospital to improve the timeliness and completeness of cancer investigations and treatment. The H2020 SELFIE consortium selected OnkoNetwork as a promising integrated care initiative in Hungary and conducted a multicriteria decision analysis based on health, patient experience, and cost outcomes. In this paper, a more detailed analysis of clinical impacts is provided in the largest subgroup, non-small cell lung cancer (NSCLC) patients. A retrospective cohort study was conducted, enrolling new cancer suspect patients with subsequently confirmed NSCLC in two annual periods, before and after OnkoNetwork implementation (control and intervention cohorts, respectively). To control for selection bias and confounding, baseline balance was improved via propensity score weighting. Overall survival was analyzed in univariate and multivariate weighted Cox regression models and the effect was further characterized in a counterfactual analysis. Our analysis included 123 intervention and 173 control NSCLC patients from early to advanced stage, with significant between-cohort baseline differences. The propensity score-based weighting resulted in good baseline balance. A large survival benefit was observed in the intervention cohort, and intervention was an independent predictor of longer survival in a multivariate analysis when all baseline characteristics were included (HR = 0.63, p = 0.039). When post-baseline variables were included in the model, belonging to the intervention cohort was not an independent predictor of survival, but the survival benefit was explained by slightly better stage distribution and ECOG status at treatment initiation, together with trends for broader use of PET-CT and higher resectability rate. In conclusion, patient navigation is a valuable tool to improve cancer outcomes by facilitating more timely and complete cancer diagnostics. Contradictory evidence in the literature may be explained by common sources of bias, including the wait-time paradox and adjustment to intermediate outcomes.</description><subject>Analysis</subject><subject>Bias</subject><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Cell survival</subject><subject>Cohort analysis</subject><subject>Cost analysis</subject><subject>Criminal investigations</subject><subject>Decision analysis</subject><subject>Diagnosis</subject><subject>Evidence-based medicine</subject><subject>Health insurance</subject><subject>Hospitals</subject><subject>Integrated delivery networks</subject><subject>Integrated delivery systems</subject><subject>Intervention</subject><subject>Lung cancer</subject><subject>Lung cancer, Non-small cell</subject><subject>Lung diseases</subject><subject>Medical diagnosis</subject><subject>Medical prognosis</subject><subject>Medicine and Health Sciences</subject><subject>Methods</subject><subject>Mortality</subject><subject>Multiple criterion</subject><subject>Multivariate analysis</subject><subject>Non-small cell lung carcinoma</subject><subject>Observational studies</subject><subject>Patients</subject><subject>Propensity scores</subject><subject>Regression analysis</subject><subject>Regression models</subject><subject>Small cell lung carcinoma</subject><subject>Subgroups</subject><subject>Survival</subject><subject>Weighting</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk12L1DAUhosouK7-A8GAIHoxY5t-ZOrFwrD4MbCwoIu34TQ5bTO0SU3SrvOb_JOmO1V2ZC-k0KbJc95z8p4kil4m8TpJWfJ-b0aroVsPRuM6pqxgSfkoOkvKlK4KGqeP742fRs-c28dxnm6K4iz6tesHayaUxI12UhN0xNREG71yPXQdERhe3agbIkALtGQAr1B7R6D24Vdpb40chQrEskQ0TKoJY6M_kC2xGAg3oPBqQiJMa6wnzo_yQG6Vb0lIP6B2yh-IE8YiuUXVtD5U1CrnjVUiBM1ZuufRkxo6hy-W73l08-njzeWX1dX1593l9moliqL0K1lLzHKsMwlYMiggT7MyryWlcRZsSITcVJglFaRVgnFeF3UZvKBFQjGFKk3Po1dH2aEzji_eOk4Z3WRZkccsELsjIQ3s-WBVD_bADSh-N2Fsw8F6JTrk-QYlSyGWLIGsxBqqqmJFWVERymR0znaxZBurHqUIBlroTkRPV7RqeWMmXuZlniezwNtFwJofIzrPe-XmtoFGMy51Fxljc92v_0Ef3t1CNRA2oHRtQl4xi_Ito1lM8-xOa_0AFR6JvQoNw1qF-ZOAdycBc1Pxp29gdI7vvn39f_b6-yn75h7bInS-daYb5_PnTsHsCIpwHp3F-q_JSczne_THDT7fI77co_Q3vQwWbg</recordid><startdate>20221025</startdate><enddate>20221025</enddate><creator>Pitter, János G</creator><creator>Moizs, Mariann</creator><creator>Ezer, Éva Somogyiné</creator><creator>Lukács, Gábor</creator><creator>Szigeti, Annamária</creator><creator>Repa, Imre</creator><creator>Csanádi, Marcell</creator><creator>Rutten-van Mölken, Maureen P. M. H</creator><creator>Islam, Kamrul</creator><creator>Kaló, Zoltán</creator><creator>Vokó, Zoltán</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6784-9215</orcidid><orcidid>https://orcid.org/0000-0002-1004-1848</orcidid><orcidid>https://orcid.org/0000-0001-8706-3159</orcidid></search><sort><creationdate>20221025</creationdate><title>Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control</title><author>Pitter, János G ; Moizs, Mariann ; Ezer, Éva Somogyiné ; Lukács, Gábor ; Szigeti, Annamária ; Repa, Imre ; Csanádi, Marcell ; Rutten-van Mölken, Maureen P. M. H ; Islam, Kamrul ; Kaló, Zoltán ; Vokó, Zoltán</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c669t-dfde45ef4dae97a6a53495fd22041931cd8be41ba3b1e05f6f93862612e3ab33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analysis</topic><topic>Bias</topic><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Cell survival</topic><topic>Cohort analysis</topic><topic>Cost analysis</topic><topic>Criminal investigations</topic><topic>Decision analysis</topic><topic>Diagnosis</topic><topic>Evidence-based medicine</topic><topic>Health insurance</topic><topic>Hospitals</topic><topic>Integrated delivery networks</topic><topic>Integrated delivery systems</topic><topic>Intervention</topic><topic>Lung cancer</topic><topic>Lung cancer, Non-small cell</topic><topic>Lung diseases</topic><topic>Medical diagnosis</topic><topic>Medical prognosis</topic><topic>Medicine and Health Sciences</topic><topic>Methods</topic><topic>Mortality</topic><topic>Multiple criterion</topic><topic>Multivariate analysis</topic><topic>Non-small cell lung carcinoma</topic><topic>Observational studies</topic><topic>Patients</topic><topic>Propensity scores</topic><topic>Regression analysis</topic><topic>Regression models</topic><topic>Small cell lung carcinoma</topic><topic>Subgroups</topic><topic>Survival</topic><topic>Weighting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pitter, János G</creatorcontrib><creatorcontrib>Moizs, Mariann</creatorcontrib><creatorcontrib>Ezer, Éva Somogyiné</creatorcontrib><creatorcontrib>Lukács, Gábor</creatorcontrib><creatorcontrib>Szigeti, Annamária</creatorcontrib><creatorcontrib>Repa, Imre</creatorcontrib><creatorcontrib>Csanádi, Marcell</creatorcontrib><creatorcontrib>Rutten-van Mölken, Maureen P. M. H</creatorcontrib><creatorcontrib>Islam, Kamrul</creatorcontrib><creatorcontrib>Kaló, Zoltán</creatorcontrib><creatorcontrib>Vokó, Zoltán</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pitter, János G</au><au>Moizs, Mariann</au><au>Ezer, Éva Somogyiné</au><au>Lukács, Gábor</au><au>Szigeti, Annamária</au><au>Repa, Imre</au><au>Csanádi, Marcell</au><au>Rutten-van Mölken, Maureen P. M. H</au><au>Islam, Kamrul</au><au>Kaló, Zoltán</au><au>Vokó, Zoltán</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control</atitle><jtitle>PloS one</jtitle><date>2022-10-25</date><risdate>2022</risdate><volume>17</volume><issue>10</issue><spage>e0276719</spage><epage>e0276719</epage><pages>e0276719-e0276719</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>OnkoNetwork is a patient navigation program established in the Moritz Kaposi General Hospital to improve the timeliness and completeness of cancer investigations and treatment. The H2020 SELFIE consortium selected OnkoNetwork as a promising integrated care initiative in Hungary and conducted a multicriteria decision analysis based on health, patient experience, and cost outcomes. In this paper, a more detailed analysis of clinical impacts is provided in the largest subgroup, non-small cell lung cancer (NSCLC) patients. A retrospective cohort study was conducted, enrolling new cancer suspect patients with subsequently confirmed NSCLC in two annual periods, before and after OnkoNetwork implementation (control and intervention cohorts, respectively). To control for selection bias and confounding, baseline balance was improved via propensity score weighting. Overall survival was analyzed in univariate and multivariate weighted Cox regression models and the effect was further characterized in a counterfactual analysis. Our analysis included 123 intervention and 173 control NSCLC patients from early to advanced stage, with significant between-cohort baseline differences. The propensity score-based weighting resulted in good baseline balance. A large survival benefit was observed in the intervention cohort, and intervention was an independent predictor of longer survival in a multivariate analysis when all baseline characteristics were included (HR = 0.63, p = 0.039). When post-baseline variables were included in the model, belonging to the intervention cohort was not an independent predictor of survival, but the survival benefit was explained by slightly better stage distribution and ECOG status at treatment initiation, together with trends for broader use of PET-CT and higher resectability rate. In conclusion, patient navigation is a valuable tool to improve cancer outcomes by facilitating more timely and complete cancer diagnostics. Contradictory evidence in the literature may be explained by common sources of bias, including the wait-time paradox and adjustment to intermediate outcomes.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><doi>10.1371/journal.pone.0276719</doi><tpages>e0276719</tpages><orcidid>https://orcid.org/0000-0002-6784-9215</orcidid><orcidid>https://orcid.org/0000-0002-1004-1848</orcidid><orcidid>https://orcid.org/0000-0001-8706-3159</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2022-10, Vol.17 (10), p.e0276719-e0276719
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2728446507
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Analysis
Bias
Cancer therapies
Care and treatment
Cell survival
Cohort analysis
Cost analysis
Criminal investigations
Decision analysis
Diagnosis
Evidence-based medicine
Health insurance
Hospitals
Integrated delivery networks
Integrated delivery systems
Intervention
Lung cancer
Lung cancer, Non-small cell
Lung diseases
Medical diagnosis
Medical prognosis
Medicine and Health Sciences
Methods
Mortality
Multiple criterion
Multivariate analysis
Non-small cell lung carcinoma
Observational studies
Patients
Propensity scores
Regression analysis
Regression models
Small cell lung carcinoma
Subgroups
Survival
Weighting
title Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T00%3A41%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improved%20survival%20of%20non-small%20cell%20lung%20cancer%20patients%20after%20introducing%20patient%20navigation:%20A%20retrospective%20cohort%20study%20with%20propensity%20score%20weighted%20historic%20control&rft.jtitle=PloS%20one&rft.au=Pitter,%20J%C3%A1nos%20G&rft.date=2022-10-25&rft.volume=17&rft.issue=10&rft.spage=e0276719&rft.epage=e0276719&rft.pages=e0276719-e0276719&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0276719&rft_dat=%3Cgale_plos_%3EA724025477%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2728446507&rft_id=info:pmid/&rft_galeid=A724025477&rft_doaj_id=oai_doaj_org_article_58ed73a0d71a49efabbb769b2cdfd723&rfr_iscdi=true